Literature DB >> 3543384

Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia.

J Verdrager.   

Abstract

A review is presented of the development of drug-resistant malaria in Païlin on the Thai-Kampuchean border and its spread to other parts of the region and beyond. Resistance of P. falciparum to chloroquine appears to have emerged in this area in the early 1960s and evidence of resistance to the combination of sulfadoxine and pyrimethamine and to the combination of diaphenylsulfone and pyrimethamine came from the same area towards the end of the same decade. The factors leading to the emergence and increase of drug resistance appear to have been: the continuous introduction of non-immune migrants to a hyperendemic malaria area, an increase in already intense transmission resulting from the living and working conditions of the migrants and prolonged drug pressure resulting from individual drug consumption and mass drug administration, particularly from the medicated salt project which covered the area in which resistance emerged. These conditions lead to the selection of resistant mutants. Moreover, resistant parasites were exposed to multiple and increasing doses of chloroquine, pyrimethamine and sulfathiazole during repeated passages through non-immune hosts who were being treated for primary attacks, early recrudescences and reinfections. This probably resulted in increasing the degree of resistance and in the selection of parasites resistant to sulfathiazole with cross-resistance to other sulfonamides. In Irian Jaya, Indonesian New Guinea, where there had been a chloroquinized salt project, the level of chloroquine resistance was much lower than in Païlin; this is associated with the absence of a non-immune population and the lower dose of chloroquine base used in the salt. The spread of chloroquine resistance is then discussed. At first resistance was found only in three foci in South-East Asia where A. balabacensis is the vector of malaria. It then spread to all A. balabacensis areas, and finally to areas outside the area of distribution of A. balabacensis. The spread of resistance is found to be favoured by the presence of the vector A. balabacensis and by the introduction of a non-immune population.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543384

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  33 in total

1.  Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.

Authors:  Nimol Khim; Christiane Bouchier; Marie-Thérèse Ekala; Sandra Incardona; Pharath Lim; Eric Legrand; Ronan Jambou; Socheat Doung; Odile Mercereau Puijalon; Thierry Fandeur
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 2.  Malaria in South Asia: prevalence and control.

Authors:  Ashwani Kumar; Laura Chery; Chinmoy Biswas; Nagesh Dubhashi; Prafulla Dutta; Virendra Kumar Dua; Mridula Kacchap; Sanjeeb Kakati; Anar Khandeparkar; Dalip Kour; Satish N Mahajan; Ardhendu Maji; Partha Majumder; Jagadish Mohanta; Pradyumna K Mohapatra; Krishnamoorthy Narayanasamy; Krishnangshu Roy; Jayanthi Shastri; Neena Valecha; Rana Vikash; Reena Wani; John White; Pradipsinh K Rathod
Journal:  Acta Trop       Date:  2012-01-08       Impact factor: 3.112

Review 3.  Antimalarial Drug Resistance: A Threat to Malaria Elimination.

Authors:  Didier Menard; Arjen Dondorp
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

Review 4.  Artemisinin resistance: current status and scenarios for containment.

Authors:  Arjen M Dondorp; Shunmay Yeung; Lisa White; Chea Nguon; Nicholas P J Day; Duong Socheat; Lorenz von Seidlein
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

Review 5.  Antimalarial drug resistance.

Authors:  Nicholas J White
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

6.  In vivo parasitological measures of artemisinin susceptibility.

Authors:  Kasia Stepniewska; Elizabeth Ashley; Sue J Lee; Nicholas Anstey; Karen I Barnes; Tran Quang Binh; Umberto D'Alessandro; Nicholas P J Day; Peter J de Vries; Grant Dorsey; Jean-Paul Guthmann; Mayfong Mayxay; Paul N Newton; Piero Olliaro; Lyda Osorio; Ric N Price; Mark Rowland; Frank Smithuis; Walter R J Taylor; François Nosten; Nicholas J White
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

7.  Origin and evolution of sulfadoxine resistant Plasmodium falciparum.

Authors:  Sumiti Vinayak; Md Tauqeer Alam; Tonya Mixson-Hayden; Andrea M McCollum; Rithy Sem; Naman K Shah; Pharath Lim; Sinuon Muth; William O Rogers; Thierry Fandeur; John W Barnwell; Ananias A Escalante; Chansuda Wongsrichanalai; Frederick Ariey; Steven R Meshnick; Venkatachalam Udhayakumar
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

8.  Emergence and Spread of kelch13 Mutations Associated with Artemisinin Resistance in Plasmodium falciparum Parasites in 12 Thai Provinces from 2007 to 2016.

Authors:  Theerayot Kobasa; Eldin Talundzic; Rungniran Sug-Aram; Patcharida Boondat; Ira F Goldman; Naomi W Lucchi; Pratin Dharmarak; David Sintasath; Mark Fukuda; Toni Whistler; John MacArthur; Venkatachalam Udhayakumar; Preecha Prempree; Nipon Chinanonwait
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 9.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.